Position in MEDP
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$345,822
+$16,583 QoQ
Shares Held
653
-37.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#462
of 691 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $16,392,769 across 8 Diagnostics & Research names. MEDP ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
15,246 | $7,643,734 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
28,242 | $5,456,919 | |
| 3 | DHR |
Danaher Corp /De/
|
8,284 | $1,577,936 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
595 | $760,118 | |
| 5 | MEDP |
Medpace Holdings, Inc.
This page
|
653 | $345,822 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,268 | $301,258 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,131 | $239,715 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
|
3,136 | $67,267 |
All Filings in MEDP
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,822 | 653 | Shares | Sole | 2026-07-29 | |
| 2025-06-30 | $329,239 | 1,049 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $302,252 | 992 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $301,332 | 907 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $299,418 | 897 | Shares | Sole | 2024-11-01 | |
| No filing history on record for this holder in this stock. | ||||||